Miami Herald looks at how oral peptide drugs are designed to get past the gut intact and reach specific targets in the body.
Recap by typeshit. Post by Miami Herald on X.
Dr Alo, a cardiologist, says he is following the cardiovascular data on these drugs closely and that it is shifting how heart disease is treated.
50:28
DOWNSIZED looks at why appetite and food noise can creep back late in the weekly cycle, and what that may say about whether a GLP-1 is still working.
Avi Roy points to trial data on drugs like Ozempic, including a 16-week study of 73 people where milkshake ratings barely changed despite reduced appetite.
Research presented at the anesthesiology meeting linked GLP-1 use with lower odds of heart attack and other heart problems. It shows an association, not proof of cause.
Philstar Life reports on FDA worries about unapproved weight loss drugs, including retatrutide, which is still in trials. Few details given, so check the source.
An explainer on how oral peptide drugs are designed to survive the gut and still reach specific targets in the body. Little detail beyond the title.
Loading…